DE602006020577D1 - Monomere und polymere linker zur konjugierung von biologischen molekülen und anderen stoffen - Google Patents
Monomere und polymere linker zur konjugierung von biologischen molekülen und anderen stoffenInfo
- Publication number
- DE602006020577D1 DE602006020577D1 DE200660020577 DE602006020577T DE602006020577D1 DE 602006020577 D1 DE602006020577 D1 DE 602006020577D1 DE 200660020577 DE200660020577 DE 200660020577 DE 602006020577 T DE602006020577 T DE 602006020577T DE 602006020577 D1 DE602006020577 D1 DE 602006020577D1
- Authority
- DE
- Germany
- Prior art keywords
- substances
- monomers
- biological molecules
- synthesis
- nucleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000126 substance Substances 0.000 title abstract 3
- 230000001268 conjugating effect Effects 0.000 title 1
- 239000000178 monomer Substances 0.000 title 1
- 229920000642 polymer Polymers 0.000 title 1
- 230000015572 biosynthetic process Effects 0.000 abstract 2
- 150000007523 nucleic acids Chemical class 0.000 abstract 2
- 102000039446 nucleic acids Human genes 0.000 abstract 2
- 108020004707 nucleic acids Proteins 0.000 abstract 2
- 238000003786 synthesis reaction Methods 0.000 abstract 2
- 239000000523 sample Substances 0.000 abstract 1
- 239000007790 solid phase Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
- A61K49/0041—Xanthene dyes, used in vivo, e.g. administered to a mice, e.g. rhodamines, rose Bengal
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6804—Nucleic acid analysis using immunogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
- A61K47/6843—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6889—Conjugates wherein the antibody being the modifying agent and wherein the linker, binder or spacer confers particular properties to the conjugates, e.g. peptidic enzyme-labile linkers or acid-labile linkers, providing for an acid-labile immuno conjugate wherein the drug may be released from its antibody conjugated part in an acidic, e.g. tumoural or environment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
- A61K49/0041—Xanthene dyes, used in vivo, e.g. administered to a mice, e.g. rhodamines, rose Bengal
- A61K49/0043—Fluorescein, used in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
- A61K49/0056—Peptides, proteins, polyamino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/02—Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/34—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
- C07C233/35—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/36—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
- C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G69/00—Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
- C08G69/02—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US69540905P | 2005-07-01 | 2005-07-01 | |
US69540805P | 2005-07-01 | 2005-07-01 | |
US69541005P | 2005-07-01 | 2005-07-01 | |
PCT/IB2006/002584 WO2007015168A2 (en) | 2005-07-01 | 2006-06-30 | Monomeric and polymeric linkers useful for conjugating biological molecules and other substances |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602006020577D1 true DE602006020577D1 (de) | 2011-04-21 |
Family
ID=37708983
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE200660020577 Active DE602006020577D1 (de) | 2005-07-01 | 2006-06-30 | Monomere und polymere linker zur konjugierung von biologischen molekülen und anderen stoffen |
Country Status (6)
Country | Link |
---|---|
US (6) | US8481697B2 (de) |
EP (4) | EP1910575B1 (de) |
AT (1) | ATE501277T1 (de) |
DE (1) | DE602006020577D1 (de) |
DK (1) | DK1907592T3 (de) |
WO (4) | WO2007026252A2 (de) |
Families Citing this family (101)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009003492A1 (en) | 2007-07-03 | 2009-01-08 | Dako Denmark A/S | Mhc multimers, methods for their generation, labeling and use |
US8481697B2 (en) | 2005-07-01 | 2013-07-09 | Dako Denmark A/S | Nucleic acid base pairs |
GB0517097D0 (en) * | 2005-08-19 | 2005-09-28 | Solexa Ltd | Modified nucleosides and nucleotides and uses thereof |
EP2155782A2 (de) | 2007-03-26 | 2010-02-24 | Dako Denmark A/S | Mhc-peptid-komplexe und anwendungen davon bei infektionskrankheiten |
CA2698390C (en) | 2007-09-18 | 2018-05-22 | Dako Denmark A/S | A rapid and sensitive method for detection of biological targets |
EP2197908A2 (de) | 2007-09-27 | 2010-06-23 | Dako Denmark A/S | Mhc-multimere in tuberkulose-diagnostika, -impfstoff und therapeutika |
DK2254592T3 (da) | 2008-02-28 | 2019-09-09 | Dako Denmark As | MHC-multimerer til Borrelia-diagnostik og sygdom |
WO2009114182A1 (en) | 2008-03-13 | 2009-09-17 | Pacific Biosciences Of California, Inc. | Labeled reactants and their uses |
US10722562B2 (en) | 2008-07-23 | 2020-07-28 | Immudex Aps | Combinatorial analysis and repair |
US10369204B2 (en) | 2008-10-02 | 2019-08-06 | Dako Denmark A/S | Molecular vaccines for infectious disease |
CN102325895B (zh) | 2009-02-19 | 2015-09-23 | 丹麦达科有限公司 | 缀合物分子 |
US9493578B2 (en) | 2009-09-02 | 2016-11-15 | Xencor, Inc. | Compositions and methods for simultaneous bivalent and monovalent co-engagement of antigens |
WO2011047680A1 (en) | 2009-10-20 | 2011-04-28 | Dako Denmark A/S | Immunochemical detection of single target entities |
DK2539355T3 (da) * | 2010-02-26 | 2017-01-02 | Ventana Med Syst Inc | IN-SITU-hybridisering med polytag-prober |
JP5953303B2 (ja) | 2010-07-29 | 2016-07-20 | ゼンコア インコーポレイテッド | 改変された等電点を有する抗体 |
EP2638392B1 (de) | 2010-11-08 | 2016-01-13 | Dako Denmark A/S | Quantifizierung von einzelzielmolekülen in histologischen proben |
WO2012076010A1 (en) | 2010-12-06 | 2012-06-14 | Dako Denmark A/S | Combined histological stain |
US9366675B2 (en) | 2011-04-19 | 2016-06-14 | Dako Denmark A/S | Method for enzyme-mediated signal amplification |
EP2705160B1 (de) * | 2011-05-06 | 2018-08-22 | Qiagen GmbH | Nukleotides and oligonukleotide mit einem über einen linker verknüpften marker |
US10551378B2 (en) * | 2011-09-09 | 2020-02-04 | Konica Minolta, Inc. | Tissue staining method |
US10851178B2 (en) | 2011-10-10 | 2020-12-01 | Xencor, Inc. | Heterodimeric human IgG1 polypeptides with isoelectric point modifications |
JP2014531908A (ja) | 2011-10-14 | 2014-12-04 | プレジデント アンド フェローズ オブ ハーバード カレッジ | 構造アッセンブリによる配列決定 |
WO2013067268A1 (en) * | 2011-11-03 | 2013-05-10 | Tripath Imaging, Inc. | Methods and compositions for preparing samples for immunostaining |
CA2853862C (en) * | 2011-11-08 | 2020-05-12 | Dako Denmark A/S | New method for evaluation of target in histological sample |
EP2776405A1 (de) | 2011-11-11 | 2014-09-17 | Pfizer Inc | 2-thiopyrimidinone |
US10227639B2 (en) | 2011-12-22 | 2019-03-12 | President And Fellows Of Harvard College | Compositions and methods for analyte detection |
US11021737B2 (en) | 2011-12-22 | 2021-06-01 | President And Fellows Of Harvard College | Compositions and methods for analyte detection |
JP6101782B2 (ja) | 2012-03-27 | 2017-03-22 | ヴェンタナ メディカル システムズ, インク. | シグナリングコンジュゲート及び使用法 |
WO2013177046A1 (en) | 2012-05-21 | 2013-11-28 | Solulink, Inc. | Methods and/or use of oligonucleotide conjugates for suppressing background due to cross-hybridization |
WO2013184754A2 (en) | 2012-06-05 | 2013-12-12 | President And Fellows Of Harvard College | Spatial sequencing of nucleic acids using dna origami probes |
US9605084B2 (en) | 2013-03-15 | 2017-03-28 | Xencor, Inc. | Heterodimeric proteins |
US10487155B2 (en) | 2013-01-14 | 2019-11-26 | Xencor, Inc. | Heterodimeric proteins |
US10968276B2 (en) | 2013-03-12 | 2021-04-06 | Xencor, Inc. | Optimized anti-CD3 variable regions |
US11053316B2 (en) | 2013-01-14 | 2021-07-06 | Xencor, Inc. | Optimized antibody variable regions |
KR102211837B1 (ko) * | 2013-01-14 | 2021-02-03 | 젠코어 인코포레이티드 | 신규한 이형이량체 단백질 |
US10131710B2 (en) | 2013-01-14 | 2018-11-20 | Xencor, Inc. | Optimized antibody variable regions |
US9701759B2 (en) | 2013-01-14 | 2017-07-11 | Xencor, Inc. | Heterodimeric proteins |
US9738722B2 (en) | 2013-01-15 | 2017-08-22 | Xencor, Inc. | Rapid clearance of antigen complexes using novel antibodies |
US10138509B2 (en) | 2013-03-12 | 2018-11-27 | President And Fellows Of Harvard College | Method for generating a three-dimensional nucleic acid containing matrix |
US10858417B2 (en) | 2013-03-15 | 2020-12-08 | Xencor, Inc. | Heterodimeric proteins |
US10106624B2 (en) | 2013-03-15 | 2018-10-23 | Xencor, Inc. | Heterodimeric proteins |
CA3093606A1 (en) | 2013-03-15 | 2014-09-18 | Xencor, Inc. | Heterodimeric proteins for induction of t cells |
EP3587448B1 (de) * | 2013-03-15 | 2021-05-19 | Xencor, Inc. | Heterodimere proteine |
US10519242B2 (en) | 2013-03-15 | 2019-12-31 | Xencor, Inc. | Targeting regulatory T cells with heterodimeric proteins |
DK2992115T3 (da) | 2013-04-30 | 2020-06-02 | California Inst Of Techn | Multipleksmærkning af molekyler ved stregkodning med sekventiel hybridisering |
US9983135B2 (en) | 2013-11-17 | 2018-05-29 | Quantum-Si Incorporated | Active-source-pixel, integrated device for rapid analysis of biological and chemical specimens |
KR20230022270A (ko) | 2014-03-28 | 2023-02-14 | 젠코어 인코포레이티드 | Cd38 및 cd3에 결합하는 이중특이적 항체 |
CN103969436B (zh) * | 2014-05-08 | 2015-09-16 | 东南大学 | 一种超灵敏碱性磷酸酶检测的新方法 |
EP3155426B1 (de) * | 2014-06-13 | 2023-07-19 | Immudex ApS | Allgemeiner nachweis und isolierung spezifischer zellen durch binden markierter moleküle |
US11098303B2 (en) | 2014-07-30 | 2021-08-24 | President And Fellows Of Harvard College | Systems and methods for determining nucleic acids |
US9921157B2 (en) | 2014-08-08 | 2018-03-20 | Quantum-Si Incorporated | Optical system and assay chip for probing, detecting and analyzing molecules |
EP3194934B1 (de) | 2014-08-08 | 2024-03-06 | Quantum-Si Incorporated | Integrierte vorrichtung zur verwendung mit einer externen lichtquelle zur sondierung, detektion und analyse von molekülen mittels lumineszenzlebensdauermessungen |
BR112017002485B1 (pt) | 2014-08-08 | 2020-12-01 | Quantum-Si Incorporated | circuito integrado e método de fotodetecção |
JP2017536556A (ja) * | 2014-10-08 | 2017-12-07 | アラトム, エルエルシー | 組織タンパク質の高分解画像化 |
JP2017536830A (ja) | 2014-11-26 | 2017-12-14 | ゼンコー・インコーポレイテッドXencor、 Inc. | Cd3及びcd38に結合するヘテロ二量体抗体 |
US10259887B2 (en) | 2014-11-26 | 2019-04-16 | Xencor, Inc. | Heterodimeric antibodies that bind CD3 and tumor antigens |
EP3223845B1 (de) | 2014-11-26 | 2021-05-19 | Xencor, Inc. | Cheterodimere antikörper zur bindung von cd3 und cd20 |
WO2016105450A2 (en) | 2014-12-22 | 2016-06-30 | Xencor, Inc. | Trispecific antibodies |
WO2016141387A1 (en) | 2015-03-05 | 2016-09-09 | Xencor, Inc. | Modulation of t cells with bispecific antibodies and fc fusions |
US10036066B2 (en) | 2015-03-17 | 2018-07-31 | Dako Denmark A/S | In situ hybridization detection method |
BR112017022340A2 (pt) | 2015-05-05 | 2018-07-10 | Pfizer | 2-tiopirimidinonas |
US10174363B2 (en) | 2015-05-20 | 2019-01-08 | Quantum-Si Incorporated | Methods for nucleic acid sequencing |
CN106338423B (zh) | 2015-07-10 | 2020-07-14 | 三斯坎公司 | 组织学染色的空间复用 |
AU2016349288A1 (en) | 2015-11-03 | 2018-05-31 | President And Fellows Of Harvard College | Method and apparatus for volumetric imaging of a three-dimensional nucleic acid containing matrix |
CN108699136B (zh) | 2015-12-07 | 2022-03-18 | Xencor股份有限公司 | 结合cd3和psma的异二聚抗体 |
EP4336184A2 (de) | 2015-12-18 | 2024-03-13 | Agilent Technologies, Inc. (A Delaware Corporation) | Chromogene peroxidasesubstrate |
CA3012705A1 (en) | 2016-02-17 | 2017-08-24 | Tesseract Health, Inc. | Sensor and device for lifetime imaging and detection applications |
WO2017160662A1 (en) * | 2016-03-12 | 2017-09-21 | The Regents Of The University Of California | Biodegradable vectors for efficient rna delivery |
AU2017257624B2 (en) | 2016-04-25 | 2023-05-25 | President And Fellows Of Harvard College | Hybridization chain reaction methods for in situ molecular detection |
WO2017218707A2 (en) | 2016-06-14 | 2017-12-21 | Xencor, Inc. | Bispecific checkpoint inhibitor antibodies |
WO2018005706A1 (en) | 2016-06-28 | 2018-01-04 | Xencor, Inc. | Heterodimeric antibodies that bind somatostatin receptor 2 |
US10793632B2 (en) | 2016-08-30 | 2020-10-06 | Xencor, Inc. | Bispecific immunomodulatory antibodies that bind costimulatory and checkpoint receptors |
EP3507385A4 (de) | 2016-08-31 | 2020-04-29 | President and Fellows of Harvard College | Verfahren zur kombination der detektion von biomolekülen in einem einzigen test mit fluoreszenter in-situ-sequenzierung |
US10501543B2 (en) | 2016-10-14 | 2019-12-10 | Xencor, Inc. | IL15/IL15Rα heterodimeric Fc-fusion proteins |
SG10202100951SA (en) | 2016-11-21 | 2021-03-30 | Nanostring Technologies Inc | Chemical compositions and methods of using same |
CN106674134B (zh) * | 2016-11-30 | 2019-01-01 | 辽宁大学 | 一种新型荧光探针及其制备方法和在检测6-硫代鸟嘌呤中的应用 |
EP3929304B1 (de) | 2016-12-16 | 2024-02-21 | Aratome LLC | Molekulare detektion mittels ligationsamplifikation |
JP7048617B2 (ja) * | 2016-12-19 | 2022-04-05 | ヴェンタナ メディカル システムズ, インク. | ペプチド核酸コンジュゲート |
CA3047826A1 (en) | 2016-12-22 | 2018-06-28 | Quantum-Si Incorporated | Integrated photodetector with direct binning pixel |
US11788123B2 (en) | 2017-05-26 | 2023-10-17 | President And Fellows Of Harvard College | Systems and methods for high-throughput image-based screening |
AU2018291497A1 (en) | 2017-06-30 | 2020-01-16 | Xencor, Inc. | Targeted heterodimeric Fc fusion proteins containing IL-15/IL-15Ra and antigen binding domains |
AU2018308098A1 (en) | 2017-07-24 | 2020-01-30 | Quantum-Si Incorporated | High intensity labeled reactant compositions and methods for sequencing |
US11312770B2 (en) | 2017-11-08 | 2022-04-26 | Xencor, Inc. | Bispecific and monospecific antibodies using novel anti-PD-1 sequences |
US10981992B2 (en) | 2017-11-08 | 2021-04-20 | Xencor, Inc. | Bispecific immunomodulatory antibodies that bind costimulatory and checkpoint receptors |
WO2019120635A1 (en) * | 2017-12-18 | 2019-06-27 | Ventana Medical Systems, Inc. | Peptide nucleic acid conjugates |
KR20200100098A (ko) | 2017-12-19 | 2020-08-25 | 젠코어 인코포레이티드 | 조작된 il-2 fc 융합 단백질 |
US10982006B2 (en) | 2018-04-04 | 2021-04-20 | Xencor, Inc. | Heterodimeric antibodies that bind fibroblast activation protein |
EP3781598A1 (de) | 2018-04-18 | 2021-02-24 | Xencor, Inc. | Auf tim-3 abzielende heterodimere fusionsproteine mit il-15-/il-15ra-fc-fusionsproteinen und tim-3-antigen-bindenden domänen |
AU2019256539A1 (en) | 2018-04-18 | 2020-11-26 | Xencor, Inc. | PD-1 targeted heterodimeric fusion proteins containing IL-15/IL-15Ra Fc-fusion proteins and PD-1 antigen binding domains and uses thereof |
CA3099909A1 (en) | 2018-05-14 | 2019-11-21 | Nanostring Technologies, Inc. | Chemical compositions and methods of using same |
AU2019288394A1 (en) | 2018-06-22 | 2021-01-07 | Quantum-Si Incorporated | Integrated photodetector with charge storage bin of varied detection time |
US20220034881A1 (en) * | 2018-09-24 | 2022-02-03 | Bristol-Myers Squibb Company | Barcoded peptide-mhc complexes and uses thereof |
EP3861016A2 (de) | 2018-10-03 | 2021-08-11 | Xencor, Inc. | Il-12-heterodimere fc-fusionsproteine |
JP7307793B2 (ja) * | 2018-11-16 | 2023-07-12 | エフ. ホフマン-ラ ロシュ アーゲー | 結合対のメンバーを有するストレプトアビジン被覆固相 |
US20220064226A1 (en) | 2018-12-17 | 2022-03-03 | Immudex Aps | Panel comprising Borrelia MHC multimers |
CA3127102A1 (en) | 2019-01-23 | 2020-07-30 | Quantum-Si Incorporated | High intensity labeled reactant compositions and methods for sequencing |
CA3132185A1 (en) | 2019-03-01 | 2020-09-10 | Xencor, Inc. | Heterodimeric antibodies that bind enpp3 and cd3 |
US11919956B2 (en) | 2020-05-14 | 2024-03-05 | Xencor, Inc. | Heterodimeric antibodies that bind prostate specific membrane antigen (PSMA) and CD3 |
WO2022192403A1 (en) | 2021-03-09 | 2022-09-15 | Xencor, Inc. | Heterodimeric antibodies that bind cd3 and cldn6 |
JP2024509274A (ja) | 2021-03-10 | 2024-02-29 | ゼンコア インコーポレイテッド | Cd3及びgpc3に結合するヘテロ二量体抗体 |
WO2023141548A2 (en) * | 2022-01-21 | 2023-07-27 | Advanced Cell Diagnostics, Inc. | Methods for detecting proteins and for co-detecting proteins and nucleic acids, and kits for the same |
Family Cites Families (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4447574A (en) | 1982-06-29 | 1984-05-08 | Standard Oil Company (Indiana) | Injection moldable amide-imide polymers containing calcium moieties |
US4447474A (en) * | 1982-08-30 | 1984-05-08 | Neefe Charles W | Method of selectively tinting soft contact lenses |
US5166315A (en) * | 1989-12-20 | 1992-11-24 | Anti-Gene Development Group | Sequence-specific binding polymers for duplex nucleic acids |
EP0333832B1 (de) * | 1987-09-22 | 1992-06-03 | Temple University | Künstliche analogen der dns-basenpaare |
US5359100A (en) * | 1987-10-15 | 1994-10-25 | Chiron Corporation | Bifunctional blocked phosphoramidites useful in making nucleic acid mutimers |
US5656731A (en) * | 1987-10-15 | 1997-08-12 | Chiron Corporation | Nucleic acid-amplified immunoassay probes |
US5766855A (en) | 1991-05-24 | 1998-06-16 | Buchardt, Deceased; Ole | Peptide nucleic acids having enhanced binding affinity and sequence specificity |
US6228982B1 (en) | 1992-05-22 | 2001-05-08 | Benget Norden | Double-stranded peptide nucleic acids |
DK51092D0 (da) | 1991-05-24 | 1992-04-15 | Ole Buchardt | Oligonucleotid-analoge betegnet pna, monomere synthoner og fremgangsmaade til fremstilling deraf samt anvendelser deraf |
US5539082A (en) | 1993-04-26 | 1996-07-23 | Nielsen; Peter E. | Peptide nucleic acids |
US5641625A (en) | 1992-05-22 | 1997-06-24 | Isis Pharmaceuticals, Inc. | Cleaving double-stranded DNA with peptide nucleic acids |
US5714331A (en) | 1991-05-24 | 1998-02-03 | Buchardt, Deceased; Ole | Peptide nucleic acids having enhanced binding affinity, sequence specificity and solubility |
US5719262A (en) | 1993-11-22 | 1998-02-17 | Buchardt, Deceased; Ole | Peptide nucleic acids having amino acid side chains |
AU4406793A (en) * | 1992-06-04 | 1993-12-30 | Clover Consolidated, Limited | Water-soluble polymeric carriers for drug delivery |
GB9211979D0 (en) | 1992-06-05 | 1992-07-15 | Buchard Ole | Uses of nucleic acid analogues |
US5527675A (en) | 1993-08-20 | 1996-06-18 | Millipore Corporation | Method for degradation and sequencing of polymers which sequentially eliminate terminal residues |
DE4331012A1 (de) | 1993-09-13 | 1995-03-16 | Bayer Ag | Nukleinsäuren-bindende Oligomere mit N-Verzweigung für Therapie und Diagnostik |
US7375198B2 (en) * | 1993-10-26 | 2008-05-20 | Affymetrix, Inc. | Modified nucleic acid probes |
US5538848A (en) | 1994-11-16 | 1996-07-23 | Applied Biosystems Division, Perkin-Elmer Corp. | Method for detecting nucleic acid amplification using self-quenching fluorescence probe |
GB2284209A (en) | 1993-11-25 | 1995-05-31 | Ole Buchardt | Nucleic acid analogue-induced transcription of RNA from a double-stranded DNA template |
IL112759A0 (en) * | 1994-02-25 | 1995-05-26 | Khepri Pharmaceuticals Inc | Novel cysteine protease inhibitors |
US5705333A (en) | 1994-08-05 | 1998-01-06 | The Regents Of The University Of California | Peptide-based nucleic acid mimics(PENAMS) |
US5681702A (en) * | 1994-08-30 | 1997-10-28 | Chiron Corporation | Reduction of nonspecific hybridization by using novel base-pairing schemes |
US6361951B1 (en) * | 1995-06-27 | 2002-03-26 | The University Of North Carolina At Chapel Hill | Electrochemical detection of nucleic acid hybridization |
US20040033973A1 (en) * | 2002-08-16 | 2004-02-19 | Muthiah Manoharan | Compounds and oligomeric compounds comprising novel nucleobases |
WO1998002580A2 (en) * | 1996-07-12 | 1998-01-22 | Tm Technologies, Inc. | Signal amplification method |
EP2319855B1 (de) * | 1997-01-08 | 2016-04-06 | Sigma-Aldrich Co. LLC | Biokonjugation von Makromolekülen |
US6107470A (en) | 1997-05-29 | 2000-08-22 | Nielsen; Peter E. | Histidine-containing peptide nucleic acids |
US6294331B1 (en) * | 1997-08-08 | 2001-09-25 | The United States Of America As Represented By The Department Of Health And Human Services | Methods for assessing genetic and phenotypic markers by simultaneous multicolor visualization of chromogenic dyes using brightfield microscopy and spectral imaging |
US6342381B1 (en) | 1998-02-27 | 2002-01-29 | Buckman Laboratories Internationals, Inc. | Enzyme stabilization with pre-superpolyamide or pre-fiber-forming polyamide oligomers |
US6287772B1 (en) * | 1998-04-29 | 2001-09-11 | Boston Probes, Inc. | Methods, kits and compositions for detecting and quantitating target sequences |
WO2000068434A2 (en) | 1999-05-07 | 2000-11-16 | Yale University | Multiple tag analysis |
JP2001252097A (ja) | 2000-03-10 | 2001-09-18 | Fuji Photo Film Co Ltd | 核酸ハイブリダイゼーションの効率化法 |
US6451588B1 (en) | 2000-06-30 | 2002-09-17 | Pe Corporation (Ny) | Multipartite high-affinity nucleic acid probes |
JP2004531700A (ja) | 2001-02-05 | 2004-10-14 | グラフィニティー、ファーマスーティカルス アーゲー | 低親和性スクリーニング法 |
WO2002068695A2 (en) * | 2001-02-22 | 2002-09-06 | Arcturus Engineering, Inc. | Quantitative immunohistochemistry (qihc) |
EP1377686A4 (de) * | 2001-04-12 | 2007-07-25 | Caliper Life Sciences Inc | Systeme und verfahren für genetische analyse mit hohem durchsatz |
JP2005509028A (ja) * | 2001-10-09 | 2005-04-07 | バーテックス ファーマシューティカルズ インコーポレイテッド | アスパラギン酸およびグルタミン酸誘導体ならびにそのジアゾケトン中間体を合成するための方法 |
AU2003230717A1 (en) | 2002-03-21 | 2003-10-08 | Boston Probes, Inc. | Pna oligomers, oligomers sets, methods and kits pertaining to the detection of bacillus anthracis |
WO2003083440A2 (en) * | 2002-03-29 | 2003-10-09 | Genentech, Inc. | Methods and compositions for detection and quantitation of nucleic acid analytes |
WO2004091542A2 (en) * | 2003-04-15 | 2004-10-28 | Covx Pharmaceuticals, Inc. | Nitrogen containing integrin targeting compounds |
US7256198B2 (en) * | 2004-02-18 | 2007-08-14 | Wyeth | Pyrimidoindolones and methods for using same |
WO2006016978A1 (en) | 2004-06-30 | 2006-02-16 | Applera Corporation | Analog probe complexes |
US8481697B2 (en) | 2005-07-01 | 2013-07-09 | Dako Denmark A/S | Nucleic acid base pairs |
-
2006
- 2006-06-30 US US11/993,565 patent/US8481697B2/en not_active Expired - Fee Related
- 2006-06-30 EP EP06809193.3A patent/EP1910575B1/de not_active Not-in-force
- 2006-06-30 AT AT06808856T patent/ATE501277T1/de not_active IP Right Cessation
- 2006-06-30 WO PCT/IB2006/003123 patent/WO2007026252A2/en active Application Filing
- 2006-06-30 US US11/993,528 patent/US8741566B2/en active Active
- 2006-06-30 EP EP06842206.2A patent/EP1919930B1/de not_active Not-in-force
- 2006-06-30 WO PCT/IB2006/003306 patent/WO2007045998A2/en active Application Filing
- 2006-06-30 DE DE200660020577 patent/DE602006020577D1/de active Active
- 2006-06-30 WO PCT/IB2006/003130 patent/WO2007023390A2/en active Application Filing
- 2006-06-30 EP EP20060820855 patent/EP1920072A2/de not_active Withdrawn
- 2006-06-30 EP EP20060808856 patent/EP1907592B1/de active Active
- 2006-06-30 DK DK06808856T patent/DK1907592T3/da active
- 2006-06-30 US US11/993,571 patent/US9017992B2/en active Active
- 2006-06-30 WO PCT/IB2006/002584 patent/WO2007015168A2/en active Application Filing
- 2006-06-30 US US11/993,545 patent/US8546309B2/en active Active
-
2013
- 2013-08-21 US US13/971,996 patent/US9598720B2/en active Active
-
2014
- 2014-04-14 US US14/251,934 patent/US9340824B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US20100120054A1 (en) | 2010-05-13 |
WO2007026252A3 (en) | 2007-09-13 |
EP1920072A2 (de) | 2008-05-14 |
US20100221705A1 (en) | 2010-09-02 |
EP1907592A2 (de) | 2008-04-09 |
US20140080145A1 (en) | 2014-03-20 |
EP1910575B1 (de) | 2014-12-10 |
EP1919930B1 (de) | 2016-09-14 |
US20110177500A1 (en) | 2011-07-21 |
WO2007023390A3 (en) | 2007-08-02 |
US9598720B2 (en) | 2017-03-21 |
WO2007045998A3 (en) | 2008-04-10 |
WO2007045998A2 (en) | 2007-04-26 |
WO2007026252A2 (en) | 2007-03-08 |
EP1910575A2 (de) | 2008-04-16 |
WO2007015168A2 (en) | 2007-02-08 |
DK1907592T3 (da) | 2011-06-27 |
WO2007023390A2 (en) | 2007-03-01 |
ATE501277T1 (de) | 2011-03-15 |
WO2007015168A3 (en) | 2007-08-30 |
US20100105030A1 (en) | 2010-04-29 |
US9340824B2 (en) | 2016-05-17 |
US8481697B2 (en) | 2013-07-09 |
US20140315204A1 (en) | 2014-10-23 |
EP1907592B1 (de) | 2011-03-09 |
US9017992B2 (en) | 2015-04-28 |
EP1919930A2 (de) | 2008-05-14 |
US8741566B2 (en) | 2014-06-03 |
US8546309B2 (en) | 2013-10-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE602006020577D1 (de) | Monomere und polymere linker zur konjugierung von biologischen molekülen und anderen stoffen | |
Trauger et al. | Extension of sequence-specific recognition in the minor groove of DNA by pyrrole− imidazole polyamides to 9− 13 base pairs | |
WO2008098100A3 (en) | Detection of molecule proximity | |
Nguyen et al. | Measuring single small molecule binding via rupture forces of a split aptamer | |
WO2012071428A3 (en) | Methods and/or use of oligonucleotide conjugates for assays and detections | |
Häner et al. | Oligopyrenotides: abiotic, polyanionic oligomers with nucleic acid-like structural properties | |
EP2677039A3 (de) | Erkennung von Nukleinsäuretargets mithilfe chemisch reaktiver Oligonnucleotidsonden | |
WO2005017205A3 (en) | Nucleic acid mapping using linear analysis | |
WO2007070572A3 (en) | Probe for nucleic acid sequencing and methods of use | |
WO2012058638A3 (en) | Nucleic acid nanostructure barcode probes | |
GB0511116D0 (en) | Preparation of soluble and collodial imprinted polymers by living polymerization | |
BRPI0209933B8 (pt) | proteína de fusão, e, molécula de ácido nucleico | |
EP2048149A3 (de) | Linker und ko-koppelnde Wirkstoffe zur Optimierung der Oligonukleotid-Synthese und Reinigung auf fester Unterlage | |
ATE542922T1 (de) | 2'-terminator-assoziierte pyrophosphorolyse- aktivierte polymerisierung | |
ATE534748T1 (de) | Direkter snp-nachweis mit nichtamplifizierter dna | |
EP2245135A4 (de) | Analysegeräte für kleine moleküle und proteine auf der basis von molekular geprägten polymeren | |
AU1240201A (en) | Tag library compounds, compositions, kits and methods of use | |
WO2007135368A3 (en) | Dye compounds and the use of their labelled conjugates | |
ATE551349T1 (de) | Methode unter verwendung von reversibel blockierten markierungsoligonukleotiden | |
WO2004007692A3 (en) | Methods and compositions for analyzing polymers using chimeric tags | |
ATE533791T1 (de) | Mit einer polymerisierbaren gruppierung funktionalisiertes hydrogel und anwendungen davon als biosensoren oder bioreaktoren | |
ATE496943T1 (de) | Biotinylierte mhc-komplexe und ihre verwendungen | |
Wu et al. | New class of heterogeneous helical peptidomimetics | |
BR0112400A (pt) | Ensaio de hibridização triplex mediado por cátions | |
WO2012078761A3 (en) | Dimeric molecular complexes with free cysteine residues and conjugates thereof |